Colorectal cancer
1 million new cases diagnosed each year year in the world
700.000 deaths
Symptoms
changes in intestinal transit (constipation / diarrhea)
weight loss
fresh blood in the feces
chronic fatigue
Tratament chirurgical
open surgery
minimally invasive surgery (laparoscopic / robotic) – with a growing popularity worldwide
BOTH OPTIONS WITH THE SAME ONCOLOGICAL RESULTS.
MINIMALLY INVASIVE SURGERY HAS THE ADVANTAGE OF FASTER RECOVERY.
5 years survival
depending on the stage of the disease up to 90%
Hepato-biliary-pancreatic cancer
450,000 new cases diagnosed in the world each year
430,000 deaths each year
Symptoms
The most common symptoms in pancreatic cancer are: yellowing of the skin (jaundice), marked weight loss, chronic fatigue, lack of appetite.
Treatment
surgical,
radiotherapy,
chemotherapy,
immunotherapy.
Prognosis
In the case of pancreatic cancer, 5-year survival is very low, reaching up to 10%, so an early diagnosis is particularly important.
Oromaxillofacial cancers
650,000 new cases diagnosed each year
300,000 deaths each year
Diagnostic
The diagnosis of oromaxillofacial cancers is based on the patient’s presentation to the doctor and the clinical examination performed by a professional.
The clinical examination lasts only a few minutes.
Treatment
surgical (not always indicated)
radiotherapy
concomitant radiotherapy / chemotherapy
Prognosis
Depending on the stage of the disease, 5-year survival of up to 60%
The evolution of surgical and radiotherapy techniques as well as the addition of concomitant chemotherapy did not lead to much improved treatment outcomes, which were closely correlated with the stage of the disease at the time of diagnosis.
Gynecological cancers
800,000 new cases diagnosed each year
500,000 deaths each year
Symptoms
The most common symptoms in gynecological cancers are: vaginal discharge, pelvic pain / pressure, urinary disorders, bloating, loss of appetite.
Treatment
surgical
radiotherapy
chemotherapy
hormone therapy
biological treatment
Prognosis
Depending on the stage of the disease, 5-year survival of up to 98% in the case of ovarian cancer.